Fujian Wanchen Biotechnology Group Co.,Ltd. (SHE:300972)

SHE:300972 Revenue

Fujian Wanchen Biotechnology Group had revenue of 13.98B CNY in the quarter ending September 30, 2025, with 44.15% growth. This brings the company's revenue in the last twelve months to 48.28B, up 93.06% year-over-year. In the year 2024, Fujian Wanchen Biotechnology Group had annual revenue of 32.33B with 247.86% growth.

• Revenue (ttm): 48.28B
• Revenue Growth: +93.06%
• P/S Ratio: 0.72
• Revenue / Employee: 6.11M
• Employees: 7,904
• Market Cap: 34.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	32.33B	23.04B	247.86%
Dec 31, 2023	9.29B	8.74B	1,592.03%
Jan 1, 2023	549.26M	114.56M	26.35%
Jan 1, 2022	434.70M	-15.28M	-3.40%
Dec 31, 2020	449.98M	-925.68K	-0.21%